Bill > SB1452

This bill updates Hawaii's Uniform Controlled Substance Act by expanding and modifying the lists of controlled substances in different schedules, primarily in Schedule I and Schedule IV. The bill adds numerous new synthetic opioids, hallucinogenic substances, stimulants, and other drugs to the controlled substances lists, including emerging compounds like Brorphine, Butonitazene, Eutylone, and various fentanyl analogs. These additions are intended to keep the state's drug regulations consistent with federal standards and to address new psychoactive substances that may pose public health risks. The bill makes technical changes to the existing law, such as renumbering lists, clarifying language, and ensuring that isomers, salts, and derivatives of these substances are also regulated. The changes will take effect on July 1, 2025, giving state agencies and law enforcement time to prepare for the updated regulations. The primary goal is to provide comprehensive control over potentially dangerous substances and prevent their misuse.

Government Affairs, Health and Social Services, Justice

https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SB&billnumber=1452&year=2025